US Influenza Diagnostics Market Research Analysis and …


(MENAFN-GetNews) According to a new report released by Grand View Research, influenza is a contagious disease. Therefore, there is easy transmission of the disease in public places by infected patients who are often carriers of the disease. Rising prevalence of the disease in the United States is expected to propel the market

The U.S. Influenza Diagnostics Market the size should reach $ 166.0 million year round 2026 grow up to one 5.4% CAGR according to a new report from Grand View Research, Inc. The main drivers of the market include the increasing prevalence of the disease, increasing geriatric population and population at high risk of influenza like children, pregnant women and immunocompromised patients with various chronic diseases.

The increase in influenza prevalence in the United States is expected to drive the market growth. Data from the CDC indicates that the incidence of influenza was relatively low during the months of October 2018 and November 2018, however, an increase in the number of cases was observed in December 2018 and remained high until February. 2019. Influenza A was dominant in the south-eastern part of the country. United States During the 2018-2019 influenza season, 536,301 samples were tested in laboratories, of which 54,381 tested positive, including 52,028 for influenza A and 2,353 for influenza B. These facts are telling. the increasing prevalence of influenza, necessitating an increasing demand for diagnostic products.

In addition, those at high risk of contracting the influenza virus include children, pregnant women, immunocompromised patients with chronic illnesses, and healthcare workers. For example, 28 pediatric deaths were reported by the CDC in 2018-2019, indicating the increased incidence of the disease. According to the CDC in 2018-19, 1,654 people aged 65 and over were diagnosed with the flu. Due to their immunocompromised state, this population group is more susceptible to influenza and other infectious diseases causing complications. Thus, rapid diagnosis facilitated by home care test kits is further expected to fuel the market growth during the forecast period.

RDITs held the largest market share in 2018 because they are readily available and user-friendly, which facilitates rapid diagnosis. In addition, the main participants are engaged in various inorganic and organic strategic developments to expand their existing product portfolios and geographic expansion. For example, in 2018, Quidel Corporation received 510 (k) clearance from the FDA for its CLIA-exempt QuickVue Influenza A + B test to be used for the rapid diagnosis of influenza A and B. This test facilitates detection rapid influenza B and A antigens in nasopharyngeal and nasal swabs of patients.

Hospitals held the largest market share in 2018 due to the increased prevalence of influenza. POCT is one of the fastest growing segments thanks to the technologically advanced products offered by the major players. For example, in 2016, Becton, Dickinson, and Company released a new BD Veritor Plus wireless system which is a rapid diagnostic device for the detection of virus subtypes B and A. This product is used in hospitals, clinics and laboratories. The BD Veritor Plus System is a BD cloud connectivity solution that allows users to securely transfer data to an electronic medical record. These factors are therefore expected to have a positive impact on the market potential during the forecast period.

Browse the full report with the table of contents @

Highlights of the U.S. Influenza Diagnostics Market Report

• RIDT’s commercial availability and rapid turnaround times are major factors behind its large market share.

• The US hospital influenza diagnostics market held the largest market share in 2018, but is expected to gradually slow down with the advent of POCT.

• Some of the major players in the US influenza diagnostics market are Alere, 3M Health Care, Meridian Bioscience, Inc., Becton, Dickinson and Company, Quidel Corporation, Meridian Bioscience, Inc., SA Scientific, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc. and Sekisui Diagnostics.

To request a copy of this report, please visit @

Segmentation of the US influenza diagnostics market

Grand View Research has segmented the U.S. Influenza Diagnosis Market report on the basis of test type and end use:

Outlook test type (Revenue, Million USD, 2015 – 2026)



• Cell culture

• Others

Outlook End Use Type (Revenue, USD Million, 2015 – 2026)

• Hospital


• Laboratories

Find out more or share your questions if any prior to purchase on this report @

Browse more related reports:

Analysis report of Influenza Diagnostics Market Size, Share and Trend by Test Type (RIDT, RT-PCR, Cell Culture), by End Use (Hospitals, Laboratories, POCT), by Region and Segment forecast, 2018-2024

About Grand View Search

Grand View Research is a market research and consulting company that offers market research reports, syndicated reports and personalized reports. The company is headquartered in San Francisco, California. It offers customer engagement for business consulting and market intelligence in various fields. The clientele is based in various countries with queries from over 50 industries around the world.

Grand View Research helps clients make informed decisions by helping them understand current trends and scenarios. Each year, Grand View Research performs more than 300 multi-country market studies to optimize advice to clients.

Legal warning: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility for the accuracy, content, images, videos, licenses, completeness, legality or reliability of the information contained in this article. If you have any complaints or copyright issues related to this item, please contact the supplier above.

Source link


Leave A Reply